Document Detail

Increased red cell 2,3-diphosphoglycerate levels in haemodialysis patients treated with erythropoietin.
MedLine Citation:
PMID:  8302459     Owner:  NLM     Status:  MEDLINE    
The efficacy of recombinant human erythropoietin (rHuEpo) for the treatment of renal anaemia is well established. To assess the effect of rHuEpo treatment on physical performance we evaluated physical working capacity, oxygen uptake and red cell 2,3-diphosphoglycerate (DPG) values at rest and during and after exercise on a bicycle spiroergometer in eight chronically haemodialysed patients. Follow-up examination was carried out after a mean of 14 weeks (range 9-19 weeks), when mean haemoglobin had increased from 7.8 to a stable value of 13.0 g/dl in response to rHuEpo treatment (P < 0.001). Physical working capacity and oxygen uptake at the anaerobic threshold (4 mmol/l blood lactate concentration) increased from 68 +/- 12 to 80 +/- 16 watts and 0.95 +/- 0.14 to 1.10 +/- 0.20 l/min, respectively (P < 0.01). DPG, which determines oxygen affinity to haemoglobin in red cells, increased by 13% from 13.7 +/- 1.5 to 15.5 +/- 2.2 mumol/g Hb (P < 0.05). With maximal exercise mean DPG values significantly decreased to a much lower level without rHuEpo treatment than after correction of anaemia. Therefore rHuEpo treatment results both in better oxygen transport capacity and reduced intraerythrocytic oxygen affinity, which is followed by improved oxygen delivery to tissues per unit of haemoglobin. These effects may explain the improvement of exercise capacity observed in dialysis patients after rHuEpo treatment.
J H Horina; G Schwaberger; H Brussee; G Sauseng-Fellegger; H Holzer; G J Krejs
Related Documents :
16770469 - Arterioles' contribution to oxygen supply to the skeletal muscles at rest.
23262159 - Emotional vitality: concept of importance for rehabilitation.
15481269 - Comparison of four demand oxygen delivery systems at rest and during exercise for chron...
24160189 - Whole-body vibration training as complement to programs aimed at weight loss.
14264839 - Effect of oxygen-supply rates on growth of escherichia coli. ii. comparison of results ...
3677809 - Intra-subject variability of noninvasive oxygen measurements.
23206309 - Exercise training-induced adaptations associated with increases in skeletal muscle glyc...
14499229 - Influence of endogenous oestrogens on qt interval duration.
464029 - Treatment with a position feedback-controlled head stabilizer.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association     Volume:  8     ISSN:  0931-0509     ISO Abbreviation:  Nephrol. Dial. Transplant.     Publication Date:  1993  
Date Detail:
Created Date:  1994-03-08     Completed Date:  1994-03-08     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  8706402     Medline TA:  Nephrol Dial Transplant     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  1219-22     Citation Subset:  IM    
Department of Medicine, Karl Franzens University, Graz, Austria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anemia / drug therapy,  metabolism
Diphosphoglyceric Acids / blood*
Erythrocytes / chemistry*
Erythropoietin / pharmacology*,  therapeutic use
Middle Aged
Oxygen / metabolism
Physical Exertion
Recombinant Proteins / pharmacology
Renal Dialysis*
Reg. No./Substance:
0/Diphosphoglyceric Acids; 0/Recombinant Proteins; 11096-26-7/Erythropoietin; 138-81-8/2,3-Diphosphoglycerate; 7782-44-7/Oxygen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Does erythropoietin cause hormonal changes in haemodialysis patients?
Next Document:  Adherence of human monocytes to haemodialysis membranes.